Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

FUNGIZONE

AMPHOTERICIN B

Standard Dose
3%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview FUNGIZONE is listed in Drugs@FDA under application 060570 (ANDA).

Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength LOTION;TOPICAL - 3% Sponsor APOTHECON Submission history Latest submission status date: 1995-10-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview FUNGIZONE is listed in Drugs@FDA under application 060570 (ANDA). Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength LOTION;TOPICAL - 3% Sponsor APOTHECON Submission history Latest submission status date: 1995-10-06 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.